{"uri": "eng-9433441", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Private_placement", "type": "wiki", "score": 100, "label": {"eng": "Private placement"}}, {"uri": "http://en.wikipedia.org/wiki/Monoclonal_antibody", "type": "wiki", "score": 70, "label": {"eng": "Monoclonal antibody"}}, {"uri": "http://en.wikipedia.org/wiki/Preferred_stock", "type": "wiki", "score": 70, "label": {"eng": "Preferred stock"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 61, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 48, "label": {"eng": "Nasdaq"}}, {"uri": "http://en.wikipedia.org/wiki/RA_Capital_Management", "type": "wiki", "score": 39, "label": {"eng": "RA Capital Management"}}, {"uri": "http://en.wikipedia.org/wiki/OrbiMed", "type": "wiki", "score": 39, "label": {"eng": "OrbiMed"}}, {"uri": "http://en.wikipedia.org/wiki/Transaction_cost", "type": "wiki", "score": 39, "label": {"eng": "Transaction cost"}}, {"uri": "http://en.wikipedia.org/wiki/Hidradenitis_suppurativa", "type": "wiki", "score": 38, "label": {"eng": "Hidradenitis suppurativa"}}, {"uri": "http://en.wikipedia.org/wiki/GlobeNewswire", "type": "org", "score": 33, "label": {"eng": "GlobeNewswire"}}, {"uri": "http://en.wikipedia.org/wiki/Rockville,_Maryland", "type": "loc", "score": 33, "label": {"eng": "Rockville, Maryland"}, "location": {"type": "place", "label": {"eng": "Rockville, Maryland"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Institutional_investor", "type": "wiki", "score": 26, "label": {"eng": "Institutional investor"}}], "eventDate": "2024-03-27", "totalArticleCount": 7, "title": {"eng": "Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?"}, "summary": {"eng": "The first big update worth noting is the company securing $185 million through a private placement. This funding comes from an agreement with institutional investors.\n\nThe private placement includes $115.6 million of non-voting convertible preferred stock and warrants worth another $69.4 million. Avalo Therapeutics expects net upfront proceeds of $105 million from this private placement.\n\nAvalo Therapeutics is also up today after completing its acquisition of AlmataBio. The company did so to acqu"}, "location": {"type": "place", "label": {"eng": "Rockville, Maryland"}, "country": {"type": "country", "label": {"eng": "United States"}}}, "categories": [{"uri": "dmoz/Business/Investing", "label": "dmoz/Business/Investing", "wgt": 72}, {"uri": "dmoz/Home/Personal_Finance/Investing", "label": "dmoz/Home/Personal Finance/Investing", "wgt": 79}, {"uri": "dmoz/Business/Investing/Guides", "label": "dmoz/Business/Investing/Guides", "wgt": 71}, {"uri": "news/Business", "label": "news/Business", "wgt": 84}], "articleCounts": {"eng": 7}, "sentiment": 0.1215686274509804, "wgt": 449193600, "relevance": 1}